Repair & Regenerative

Thymosin Alpha-1 (Thymic Peptide)

Research Use Only (RUO). Not for human or animal consumption.

Information provided for research and educational purposes only. Not intended as medical advice. Buyers must be 21 or older and responsible for compliance with local regulations.

1. Compound Identification

CAS Number
62304-98-7
Molecular Formula
C129H215N33O55
Molecular Weight
3108.3 g/mol
PubChem CID
16130571
Amino Acid Sequence
28-residue N-terminally acetylated peptide
Synonyms
Talpha1, Zadaxin, thymalfasin
Compound Category
Thymic immune-modulating peptide
First Described
1970s (Goldstein)

2. What Is Thymosin Alpha-1?

Thymosin Alpha-1 is a 28-amino-acid peptide originally isolated from the thymus gland, the organ central to immune-cell development. It is N-terminally acetylated, carries CAS number 62304-98-7, and has the molecular formula C129H215N33O55 with a molecular weight of 3108.3 g/mol.

Under the name thymalfasin (Zadaxin), this molecule is used clinically in some countries. It is studied as an immune-modulating peptide and is supplied here as a research compound in lyophilized powder form for laboratory reconstitution.

Thymosin alpha-1 is approved as a prescription medicine in a number of countries outside the United States under the name thymalfasin. It holds no approved indication in the United States, and the material listed here is a research-grade reference peptide, not that product.

3. Research Background

Thymosin Alpha-1 was identified in the 1970s through the work of Allan Goldstein and colleagues on thymic peptides. A 2001 monograph by Ancell and colleagues in the American Journal of Health-System Pharmacy summarized the early profile of thymosin alpha-1 (PubMed 11381492).

A 2016 review by King and Tuthill in Vitamins and Hormones surveyed immune modulation with thymosin alpha-1 treatment (PubMed 27450734), and a 2025 review in the International Journal of Molecular Sciences examined it in the context of aging (PubMed 41373628). It has a more developed clinical record than most peptides in this encyclopedia.

4. Mechanism of Action

In research models, Thymosin Alpha-1 is studied for effects on immune-cell function, particularly T-cell maturation and the activity of dendritic cells, with proposed signaling through Toll-like receptors. This immune-modulating profile is the focus of most of its research literature.

It is biochemically distinct from the beta-thymosin family that includes TB-500, despite the shared thymosin name. For current findings, search PubMed directly.

5. Storage and Stability

Lyophilized Thymosin Alpha-1 is generally stored at -20°C for long-term holding, with stability reported around 24 months. Refrigeration at 2°C to 8°C suits shorter windows, away from light and moisture.

The lot-specific Certificate of Analysis is the authoritative reference for a given batch.

6. Handling and Solubility Notes (Laboratory Context)

Reconstitution means returning a lyophilized compound to solution. This page gives no preparation procedure: solvent, concentration and handling steps belong to the methodology of the study being reproduced, not to a compound reference. Thymosin Alpha-1 is handled as aqueous-soluble material.

Lyophilized material is hygroscopic, so a sealed container is allowed to reach ambient temperature before it is opened. Solubility and water-content figures for a given lot appear on its Certificate of Analysis.

7. Quality Considerations for Research

Identity and purity of research-grade Thymosin Alpha-1 are established analytically, by HPLC with mass spectrometric confirmation of the expected mass. Verified purity is documented per lot on the Certificate of Analysis. The N-terminal acetylation should be reflected in the identity confirmation.

Check HPLC purity, mass-spec identity, and net peptide content on the Certificate of Analysis. peptides.com publishes lot-specific lab reports for verification.

9. Research References

Ancell CD, Phipps J, et al. (2001). Thymosin alpha-1. American Journal of Health-System Pharmacy.
PubMed 11381492

King R, Tuthill C (2016). Immune Modulation with Thymosin Alpha 1 Treatment. Vitamins and Hormones.
PubMed 27450734

Simonova MA, Ivanov I, et al. (2025). Aging and Thymosin Alpha-1. International Journal of Molecular Sciences.
PubMed 41373628

10. Available Research Products

peptides.com carries Thymosin Alpha-1 in research-grade lyophilized vials. Each ships with a batch-specific Certificate of Analysis.

These products are sold for Research Use Only and are not intended for human consumption.

Compliance Disclaimers

  • Research Use Only (RUO). Not for Human Consumption (NFHC).
  • Information provided for research and educational purposes only. Not intended as medical advice, diagnosis, or treatment.
  • Age verification: purchasers must be 21 or older. Compliance with local laws is the buyer’s responsibility.
Remove Item?

This item will be removed from your cart. You can always add it back later if you change your mind!